References
- Braveman, P. A., Cubbin, C., Egerter, S., Williams, D. R., & Pamuk, E. (2010). Socioeconomic disparities in health in the United States: What the patterns tell us. American Journal of Public Health, 100(Suppl. 1), S186–S196. https://doi.org/10.2105/AJPH.2009.166082
- Burch, L. S., Smith, C. J., Phillips, A. N., Johnson, M. A., & Lampe, F. C. (2016). Socioeconomic status and response to antiretroviral therapy in high-income countries: A literature review. AIDS, 30(8), 1147–1162. https://doi.org/10.1097/QAD.0000000000001068
- Chen, M., Dou, Z., Wang, L., Wu, Y., Zhao, D., Gan, X., Ma, Y., & Zhang, F. (2017). Gender differences in outcomes of antiretroviral treatment among HIV-infected patients in China: A retrospective cohort study, 2010–2015. Journal of Acquired Immune Deficiency Syndromes, 76(3), 281–288. https://doi.org/10.1097/qai.0000000000001500
- Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumwenda, J., Grinsztejn, B., Pilotto, J. H., Godbole, S. V., Mehendale, S., Chariyalertsak, S., Santos, B. R., Mayer, K. H., Hoffman, I. F., Eshleman, S. H., Piwowar-Manning, E., Wang, L., Makhema, J., Mills, L. A., … HPTN Study Team. (2011). Prevention of HIV-1 infection with early antiretroviral therapy. New England Journal of Medicine, 365(6), 493–505. https://doi.org/10.1056/NEJMoa1105243
- Gras, L., Kessekring, A. M., Griffin, J. T., van Sighem, A. I., Fraser, C., Ghani, A. C., Miedema, F., Reiss, P., Lange, J. M., de Wolf, F., ATHENA, & Netherlands National Observational Cohort Study. (2007). CD4 cell counts of 800 cells/mm3 or greater after 7 years of highly active antiretroviral therapy are feasible in most patients starting with 350 cells/mm3 or greater. Journal of Acquired Immune Deficiency Syndromes, 45(2), 183–192. https://doi.org/10.1097/QAI.0b013e31804d685b
- Moore, R. D., & Keruly, J. C. (2007). CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression. Journal of Biochemistry and Molecular Biology, 44(3), 441–446. https://doi.org/10.1086/510746
- Pellowski, J. A., Kalichman, S. C., Matthews, K. A., & Adler, N. (2013). A pandemic of the poor: Social disadvantage and the U.S. HIV epidemic. The American Psychologist, 68(4), 197–209. https://doi.org/10.1037/a0032694
- Shacham, E., Nurutdinova, D., Onen, N., Stamm, K., & Overton, E. T. (2010). The interplay of sociodemographic factors on virologic suppression among a U.S. Outpatient HIV clinic population. AIDS Patient Care and STDs, 24(4), 229–235. https://doi.org/10.1089/apc.2009.0275
- Shen, Y., Lu, H., Wang, Z., Qi, T., & Wang, J. (2013). Analysis of the immunologic status of a newly diagnosed HIV positive population in China. BMC Infectious Diseases, 13, 429. https://doi.org/10.1186/1471-2334-13-429
- Simoni, J. M., Yard, S. S., & Huh, D. (2013). Prospective prediction of viral suppression and immune response nine months after ART initiation in Seattle, WA. AIDS Care, 25(2), 181–185. https://doi.org/10.1080/09540121.2012.687821
- Su, S., Chen, X., Mao, L., He, J., Wei, X., Jing, J., & Zhang, L. (2016). Superior effects of antiretroviral treatment among men who have sex with men compared to other HIV at-risk populations in a large cohort study in Hunan, China. International Journal of Environmental Research and Public Health, 13, 3. https://doi.org/10.3390/ijerph13030283
- Tran, B. X., Hwang, J., Nguyen, L. H., Nguyen, A. T., Latkin, N. R., Tran, N. K., Minh Thuc, V. T., Nguyen, H. L., Phan, H. T., Le, H. T., Tran, T. D., & Latkin, C. A. (2016). Impact of socioeconomic inequality on access, adherence, and outcomes of antiretroviral treatment services for people living with HIV/AIDS in Vietnam. PLoS One, 11(12), e0168687. https://doi.org/10.1371/journal.pone.0168687
- WHO. (2015). Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. http://www.who.int/hiv/pub/guidelines/earlyrelease-arv/en/
- Xu, J., Sullivan, S. G., Dou, Z., & Wu, Z., & China CIPRA Project 2 Team. (2007). Economic stress and HIV-associated health care utilization in a rural region of China: A qualitative study. AIDS Patient Care and STDs, 21(11), 787–798. https://doi.org/10.1089/apc.2007.0005
- Yang, X., Li, X., Qiao, S., Zhang, Q., Shen, Z., & Zhou, Y. (2019). Immunological and virologic outcomes of people living with HIV in Guangxi, China: 2012–2017. PLoS One, 14(3), e0213205. https://doi.org/10.1371/journal.pone.0213205
- Zaragoza-Macias, E., Cosco, D., Nguyen, M. L., Del Rio, C., & Lennox, J. (2010). Predictors of success with highly active antiretroviral therapy in an antiretroviral-naive urban population. AIDS Research and Human Retroviruses, 26(2), 133–138. https://doi.org/10.1089/aid.2009.0001
- Zeng, C., Li, X., Qiao, S., Yang, X., Shen, Z., & Zhou, Y. (2020). Anticipated stigma and medication adherence among people living with HIV: The mechanistic roles of medication support and ART self-efficacy. AIDS Care. In press. https://doi.org/10.1080/09540121.2020.1728213
- Zhang, F. J., Pan, J., Yu, L., Wen, Y., & Zhao, Y. (2005). Current progress of China's free ART program. Cell Research, 15(11-12), 877–882. https://doi.org/10.1038/sj.cr.7290362